0001672981-16-000001.txt : 20160502 0001672981-16-000001.hdr.sgml : 20160502 20160502073133 ACCESSION NUMBER: 0001672981-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160502 DATE AS OF CHANGE: 20160502 EFFECTIVENESS DATE: 20160502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. CENTRAL INDEX KEY: 0001672981 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-262383 FILM NUMBER: 161609736 BUSINESS ADDRESS: STREET 1: 36 IRVING STREET, #3 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617 678 3113 MAIL ADDRESS: STREET 1: 36 IRVING STREET, #3 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0707 D LIVE 0001672981 Gemini Therapeutics, Inc. 36 IRVING STREET, #3 CAMBRIDGE MA MASSACHUSETTS 02138 617 678 3113 DELAWARE None None Corporation true 2015 James McLaughlin 36 Irving Street, #3 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Jean George 500 Boylston Street, Suite 1380 c/o Lightstone Ventures Boston MA MASSACHUSETTS 02116 Director Jason Rhodes 400 Technology Square, 10th Floor c/o Atlas Venture Fund X L.P. Cambridge MA MASSACHUSETTS 02139 Director Carl Gordon 601 Lexington Avenue, 54th Floor c/o OrbiMed Advisors LLC New York NY NEW YORK 10022 Director Biotechnology Decline to Disclose 06b false 2016-04-19 false true true true Convertible Notes false 0 2000001 2000001 0 false 4 0 0 0 false Gemini Therapeutics, Inc. James McLaughlin James McLaughlin President 2016-05-02